Details for New Drug Application (NDA): 202036
✉ Email this page to a colleague
The generic ingredient in VENLAFAXINE HYDROCHLORIDE is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
Summary for 202036
Tradename: | VENLAFAXINE HYDROCHLORIDE |
Applicant: | Yaopharma Co Ltd |
Ingredient: | venlafaxine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 202036
Mechanism of Action | Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 202036
Suppliers and Packaging for NDA: 202036
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 202036 | ANDA | Yaopharma Co., Ltd. | 50771-001 | 50771-001-02 | 100 TABLET in 1 BOTTLE, PLASTIC (50771-001-02) |
VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 202036 | ANDA | Yaopharma Co., Ltd. | 50771-002 | 50771-002-02 | 100 TABLET in 1 BOTTLE, PLASTIC (50771-002-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | May 28, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 37.5MG BASE | ||||
Approval Date: | May 28, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | May 28, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription